Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04497922
Other study ID # 2020P002382
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 25, 2021
Est. completion date May 15, 2021

Study information

Verified date January 2021
Source Brigham and Women's Hospital
Contact Peter R Chai, MD
Phone 617-632-5640
Email pchai@bwh.harvard.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Communication with patients on their clinical status is important in delivering care in the emergency department. During times of high volume or complex patients, there may be lapses in communicating with patients about their hospital course or plans of action. These miscommunications may be enhanced during the current COVID-19 pandemic as there is minimized in-person interaction with patients in order to conserve personal protective equipment and decrease the risk of disease transmission. This study utilizes a virtual white board to deliver updates to patients about the status of their emergency department stay.


Description:

The ultimate goal of this study is to understand the effect of delivering timely information about a patient's emergency department course of their satisfaction surrounding the emergency department stay. The experience of patients in the emergency department has been significantly altered by the COVID-19 pandemic due to decreased in-person encounters, and the use of PPE. Delivering information about their clinical course and expected hospital course is more difficult now given the emphasis on less in-person interaction. In response, the investigators have deployed in collaboration with e-ink, a virtual e-paper white board that can be remotely edited to help display pertinent hospital course information to patients in the emergency department. The investigators will conduct a randomized controlled trial to understand the effect of deploying these white boards on patient satisfaction in the emergency department.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date May 15, 2021
Est. primary completion date April 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients in emergency department at Brigham and Women's Hospital - Triaged to designated emergency department pods outfitted with virtual white board - Expected emergency department stay of at least four hours - Able to speak and read english - Not primary psychiatric complaint Exclusion Criteria: - Medically ill or otherwise deemed unable to participate by the study PI and/or treating clinical team. - Patients admitted to an inpatient bed but boarding in the emergency department over 10 hours. - Previously participated in the study. - Has COVID-19 risk flag or confirmed COVID-19 in electronic health record

Study Design


Intervention

Device:
e-ink screen
A virtual display screen developed by e-ink that displays patient status, basic demographics, care team information, pending tests and anticipated disposition
Behavioral:
Treatment as usual
Treatment as usual in the emergency department with communication of testing results, imaging and disposition by the primary clinical emergency department team.

Locations

Country Name City State
United States Brigham and Women's Hospital Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Brigham and Women's Hospital E-ink corporation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary emergency department satisfaction: likert scale Satisfaction of overall emergency department stay measured by a 1-5 likert scale, hospital developed question on satisfaction (how satisfied were you with your emergency department stay today?)- higher score is better 30 minutes after disposition decision for patient
Primary Quality of emergency department stay: likert scale Quality of information conveyed to participant (rated on 5 point likert scale on questions about quality of waiting time for test results, staff concern, perceived teamwork in the hospital) 30 minutes after disposition decision for patient
Secondary Preference for virtual white board Question on preference for virtual white board compared to a standard emergency department room without a white board (1-4 likert scale, with 4 being strongly prefer white board room) 30 minutes after disposition decision for patient
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3